GFAP and Alzheimer disease: However, when evaluated for the number of GFAP-positive cells, Ast-AD exhibited a lower number compared to Ast-Ctrl (75.6% vs. 91.2%, p < 0.05), but their numbers were similar if considering S100B-positive cells (98.2% vs. 99.9%, Figure 6D).